Article

Fourth-generation fluoroquinolones offer improved coverage

Fort Lauderdale, FL-The investigational fourth-generation fluoroquinolones moxifloxacin and gatifloxacin show prom-ising potential for providing broad- spectrum coverage against important gram-negative and gram-positive ocular pathogens, according to results of in vitro susceptibility testing presented at the annual meeting of the Association for Research in Vision and Ophthalmology.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.